Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
roche
3
×
biotech
boston blog main
boston top stories
cancer
clinical trials
deals
life sciences
national blog main
national top stories
san francisco
africa
alexion pharmaceuticals
alnylam pharmaceuticals
amgen
better ventures
boehringer ingelheim
boston
california
cancer drugs
chief operating officer
cobimetinib
diabetes
dicerna pharamceuticals
east africa
fda
genentech
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
illumina
investing
ipo
lagos
nigeria
patisiran
pharmaceutical
revolution medicines
rna interference
san francisco blog main
What
research
3
×
drug
gene
medicines
advances
africa
apparent
available
cancer
caught
causing
century
change
comes
continent
despite
dicerna
disease
disregard
entire
eye
family
genetic
genomic
hardest
hepatitis
hit
hold
hottest
hunters
infrastructure
intended
ipo
lack
left
manipulation
mapping
material
medical
new
Language
unset
Current search:
roche
×
research
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@techcrunch.com
4 years ago
Only 2% of genomic material available for research comes from Africa, 54gene wants to change that
